3 years ago1,000+ Views
Johnson & Johnson Loses Risperdal Case
The verdict is on the Johnson & Johnson lawsuit that I posted about before.

The verdict is in:

"A Philadelphia jury decided the health care giant must pay $2.5 million in damages for failing to warn that its Risperdal antipsychotic could cause gynecomastia, which is abnormal development of breasts in males."

Why is this important? Because it exposes a number of facts about corporate giant J&J:

- J&J hid the risks of gynecomastia from happening in recent years - J&J paid $2.2 billion two years ago to resolve criminal and civil allegations of illegally marketing the drug - J&J failed to disclose data showing the extent to which youngsters may develop gynecomastia - J&J says there are about 1,200 such lawsuits filed in courts around the country
J&J is still arguing that things were properly labeled, and it's not their fault it was being incorrectly marketed, but most of the evidence is against them.
Will J&J finally have to face the lies they've told?

4 Like
1 Share
Mostly I'm just psyched that someone didn't settle out of court!!! The more cases that actually go through the system, the better for the actual practice of Johnson&Johnson being changed.
3 years ago·Reply
@drwhat Yeah from what I read cases have been being settled for 5-6 years now. Finally made its way into the system.
3 years ago·Reply
@amog32 Too bad more will just settle out because J&J will want to cover this up even more as time goes on.
3 years ago·Reply